Evidence map›Paper›PMID 29497919›Full record

ArticleMolecular and cellular biochemistry2018

VEGF-A regulates sFlt-1 production in trophoblasts through both Flt-1 and KDR receptors.

Zhonglin Xiao, Songjun Li, Yan Yu, Mengxia Li, Jie Chen, Feng Wang, Jian Zhang, Weifen Deng, Qing Yang, Xiujun Fan

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular and cellular biochemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Observational
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Zhonglin XiaoShenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China.
Songjun LiReproductive Center of Shenzhen Armed Police Hospital, Shenzhen, 518023, China.
Yan YuBaoan Women's and Children's Hospital, Shenzhen, 518133, China.
Mengxia LiShenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China.
Jie ChenShenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China.
Feng WangReproductive Center of Shenzhen Armed Police Hospital, Shenzhen, 518023, China.
Jian ZhangShenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China.
Weifen DengReproductive Center of Shenzhen Armed Police Hospital, Shenzhen, 518023, China. dweifen@sina.com.
Qing YangCollege of Veterinary Medicine, Hunan Agricultural University, Changsha, 410128, China. qingyanghn@hunau.edu.cn.
Xiujun FanShenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China. xj.fan@siat.ac.cn.
Chinese Academy of Sciences · CNHunan Agricultural University · CNShenzhen Institutes of Advanced Technology · CN

Funding

National Key Research and Development Program of China 2016YFC1000402National Natural Sciences Foundation 81571445Natural Science Foundation of Guangdong Province 2016A030313178Shenzhen Basic Research Fund JCYJ2015052109 4519488
6 · The paper itself

Abstract

Studies have shown that sFlt-1 overproduction stimulated by excess VEGF of deciduous origin in trophoblasts can cause preeclampsia. However, the mechanism underlying how VEGF regulates sFtl-1 expression in trophoblasts remains unknown. To address this issue, JEG3 and HTR-8/SV neo (HTR8) trophoblast cell lines were used to investigate the signaling pathways involved in the regulation of sFlt-1 production via VEGF overexpression in vitro. JEG3 (VEGF-GFP-JEG3, V-J) and HTR8 (VEGF-GFP-HTR8, V-H) cells overexpressing VEGF165 were established by infecting the JEG3 and HTR8 cell lines with lentivirus expressing VEGF165. Both the mRNA and protein levels of VEGF and sFlt-1 were dramatically up-regulated in the V-J and V-H cells compared to the JEG3 and HTR8 cells, and they were significantly decreased after treatment with an Flt-1 receptor inhibitor (MK-2461), a KDR receptor inhibitor (XL-184), or an Flt-1 and KDR receptor inhibitor (ABT-869). The mRNA levels of sFlt-1, Flt-1, and KDR were increased in V-H cells after treatment, and the VEGF-A mRNA levels were also elevated. The migration and invasion abilities of JEG3 and HTR8 cells were decreased after VEGF overexpression, and this reduction could be reversed with VEGF receptor inhibitor treatment. In addition, after the different treatments, the cell migration rates of V-J cells were significantly increased compared with the control treatment. Taken together, these results indicate that sFlt-1 up-regulation by VEGF may be mediated by the VEGF/Flt-1 and/or VEGF/KDR signaling pathways. However, elucidating which pathway plays this key role requires further investigation.

Indexed as

Gene Expression RegulationSignal TransductionCell Line, TumorHumansProtein Kinase InhibitorsTrophoblastsVascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-1Vascular Endothelial Growth Factor Receptor-2FLT1 protein, humanKDR protein, humanProtein Kinase InhibitorsVascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-1Vascular Endothelial Growth Factor Receptor-2VEGFA protein, humanPreeclampsiasFlt-1Signaling pathwaysVEGF-A

Identifiers

PMID29497919
OpenAlexW2794059652

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.